Annual Total Expenses
$240.70 M
-$116.63 M-32.64%
31 December 2023
Summary:
Akebia Therapeutics annual total expenses is currently $240.70 million, with the most recent change of -$116.63 million (-32.64%) on 31 December 2023. During the last 3 years, it has fallen by -$431.77 million (-64.21%). AKBA annual total expenses is now -64.21% below its all-time high of $672.47 million, reached on 31 December 2020.AKBA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$49.93 M
-$2.44 M-4.66%
30 September 2024
Summary:
Akebia Therapeutics quarterly total expenses is currently $49.93 million, with the most recent change of -$2.44 million (-4.66%) on 30 September 2024. Over the past year, it has dropped by -$4.98 million (-9.07%). AKBA quarterly total expenses is now -81.08% below its all-time high of $263.96 million, reached on 30 June 2020.AKBA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.6% | -9.1% |
| 3 y3 years | -64.2% | -51.8% |
| 5 y5 years | -37.6% | -66.2% |
AKBA Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.2% | at low | -59.4% | +5.2% |
| 5 y | 5 years | -64.2% | at low | -81.1% | +5.2% |
| alltime | all time | -64.2% | +2724.1% | -81.1% | +1837.9% |
Akebia Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $49.93 M(-4.7%) |
| June 2024 | - | $52.37 M(+10.3%) |
| Mar 2024 | - | $47.48 M(-13.4%) |
| Dec 2023 | $240.70 M(-32.6%) | $54.82 M(-0.2%) |
| Sept 2023 | - | $54.91 M(-16.1%) |
| June 2023 | - | $65.47 M(-0.0%) |
| Mar 2023 | - | $65.50 M(+10.2%) |
| Dec 2022 | $357.33 M(-25.0%) | $59.43 M(-39.9%) |
| Sept 2022 | - | $98.94 M(+27.2%) |
| June 2022 | - | $77.76 M(-35.3%) |
| Mar 2022 | - | $120.19 M(-2.3%) |
| Dec 2021 | $476.15 M(-29.2%) | $123.02 M(+18.7%) |
| Sept 2021 | - | $103.64 M(-21.6%) |
| June 2021 | - | $132.25 M(+12.8%) |
| Mar 2021 | - | $117.24 M(-17.9%) |
| Dec 2020 | $672.47 M(+8.2%) | $142.82 M(+21.0%) |
| Sept 2020 | - | $118.08 M(-55.3%) |
| June 2020 | - | $263.96 M(+78.8%) |
| Mar 2020 | - | $147.60 M(-10.2%) |
| Dec 2019 | $621.29 M(+61.0%) | $164.45 M(+11.2%) |
| Sept 2019 | - | $147.88 M(-7.8%) |
| June 2019 | - | $160.33 M(+7.9%) |
| Mar 2019 | - | $148.63 M(-0.9%) |
| Dec 2018 | $385.90 M | $150.01 M(+85.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $81.01 M(-4.1%) |
| June 2018 | - | $84.45 M(+19.9%) |
| Mar 2018 | - | $70.43 M(-7.3%) |
| Dec 2017 | $257.90 M(+86.9%) | $75.95 M(+16.0%) |
| Sept 2017 | - | $65.46 M(+29.2%) |
| June 2017 | - | $50.66 M(-23.1%) |
| Mar 2017 | - | $65.84 M(+66.3%) |
| Dec 2016 | $138.00 M(+124.3%) | $39.58 M(+9.4%) |
| Sept 2016 | - | $36.18 M(-0.0%) |
| June 2016 | - | $36.19 M(+38.9%) |
| Mar 2016 | - | $26.05 M(+29.9%) |
| Dec 2015 | $61.51 M(+62.1%) | $20.05 M(+1.9%) |
| Sept 2015 | - | $19.68 M(+80.7%) |
| June 2015 | - | $10.89 M(-0.1%) |
| Mar 2015 | - | $10.90 M(+2.7%) |
| Dec 2014 | $37.94 M(+138.1%) | $10.61 M(+10.7%) |
| Sept 2014 | - | $9.58 M(+22.2%) |
| June 2014 | - | $7.84 M(-20.9%) |
| Mar 2014 | - | $9.91 M(+59.8%) |
| Dec 2013 | $15.93 M(+86.9%) | $6.20 M(+53.7%) |
| Sept 2013 | - | $4.03 M(+29.3%) |
| June 2013 | - | $3.12 M(+21.1%) |
| Mar 2013 | - | $2.58 M |
| Dec 2012 | $8.52 M | - |
FAQ
- What is Akebia Therapeutics annual total expenses?
- What is the all time high annual total expenses for Akebia Therapeutics?
- What is Akebia Therapeutics annual total expenses year-on-year change?
- What is Akebia Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly total expenses year-on-year change?
What is Akebia Therapeutics annual total expenses?
The current annual total expenses of AKBA is $240.70 M
What is the all time high annual total expenses for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total expenses is $672.47 M
What is Akebia Therapeutics annual total expenses year-on-year change?
Over the past year, AKBA annual total expenses has changed by -$116.63 M (-32.64%)
What is Akebia Therapeutics quarterly total expenses?
The current quarterly total expenses of AKBA is $49.93 M
What is the all time high quarterly total expenses for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total expenses is $263.96 M
What is Akebia Therapeutics quarterly total expenses year-on-year change?
Over the past year, AKBA quarterly total expenses has changed by -$4.98 M (-9.07%)